Recent Updates
Recently added Catalysts
TWST Positive Sentiment

Twist Bioscience to Report Fiscal 2026 Fourth Quarter and Full Year Financial Results on Thursday, November 12, 2026

Monday, October 26, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Twist Bioscience Corporation will release its fiscal 2026 fourth quarter and full year financial results on November 12, 2026. The results will cover the period ending September 30, 2026. A conference call is scheduled for 8:00 a.m. Eastern Time to discuss the results and provide updates.

Market Sentiment Analysis

POSITIVE FACTORS

  • Twist Bioscience will report financial results soon.
  • The company is engaging with analysts and investors.
  • A conference call will provide updates on performance.

Full Press Release Details

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value healthcare company, today announced that it will issue its financial results for the fiscal 2026 fourth quarter and full year ended September 30, 2026, before the opening of the market on November 12, 2026. The company plans to hold a conference call and live audio webcast for analysts and investors at 8:00 a.m. Eastern Time to discuss its financial results and provide an update

Frequently Asked Questions

When will Twist Bioscience report its financial results?

Twist Bioscience will report its results on November 12, 2026.

What period do the financial results cover?

The results cover the fiscal year ending September 30, 2026.

What time is the conference call scheduled?

The conference call is scheduled for 8:00 a.m. Eastern Time.

Who will be discussing the financial results?

Analysts and investors will be engaged during the call.

ShareAdd on Google
Tags: TWST Twist Bioscience financial results Q4 2026 conference call NASDAQ: TWST
Last updated: Oct 26, 2026

Biotech snapshot

Cash runway
$167M liquidity · $0M/mo burn
Low dilution risk